Biosecurity

177472327_8_resized.jpg

The slow death of nonproliferation norms

By Charles P. Blair | Analysis, Biosecurity, Nuclear Risk, Nuclear Weapons, Technology and Security

biology-clinic-doctor-4154.jpg

How do we control dangerous biological research?

By Filippa Lentzos | Biosecurity, Synthetic biology

The dread and the awe: Crispr’s inventor assesses her creation

By Sonia Ben Ouagrham-Gormley, Saskia Popescu | Biosecurity, Book Review, Disruptive Technologies, Technology and Security

New pathogen research rules: Gain of function, loss of clarity

By Gregory D. Koblentz, Lynn C. Klotz | Analysis, Biosecurity, Disruptive Technologies, Synthetic biology

Horsepox synthesis: A case of the unilateralist’s curse?

By Gregory Lewis | Analysis, Biosecurity

Seven of 2017’s freshest perspectives on nuclear weapons, biological threats, and more

By Dawn Stover | Biosecurity, Disruptive Technologies, Nuclear Weapons, Technology and Security, Voices of Tomorrow

Six of 2017’s best columns

By Elisabeth Eaves | Analysis, Biosecurity, Climate Change, Nuclear Energy, Nuclear Weapons

US lifts ban on funding creation of lethal viruses

By Elisabeth Eaves | Biosecurity, What We’re Reading

DARPA invests $100 million in gene-altering technology

By Elisabeth Eaves | Biosecurity, What We’re Reading

Antimicrobial resistance: an underrated biological threat

By Saskia Popescu | Biosecurity, Voices of Tomorrow

From Justin Bieber to genotypes

By Lucien Crowder | Biosecurity, Disruptive Technologies, Synthetic biology, What We’re Reading

What should the US national biodefense strategy look like?

By Laura H. Kahn | Biosecurity, Columnists